About Us |
||
![]() |
![]() |
Rose Pharma is a clinical phase biopharmaceutical company focusing on
development of novel treatments for irritable bowel syndrome (IBS) and
functional dyspepsia (FD), disorders which affect 10-20% of the general
population and which are large unmet clinical needs. The platform technology is based around glucagon-like peptide-1 (GLP-1), and the lead molecule is |